Pistoia Alliance Launches Global Community of Interest to Assess the Environmental Impact of Clinical Trials
Boston, US, 11 October 2022: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the launch of the Clinical Trials Environmental Impact Community of Interest (CoI) to measure and compare the carbon footprint of centralized (traditional site-based) and decentralized clinical trials. The initiative was started by […]
Pistoia Alliance and FDA Collaborate to Establish In Vitro Pharmacology Working Group to Accelerate Regulatory Submissions
Boston, US, September 13, 2022: The Pistoia Alliance a global not-for-profit that advocates for greater collaboration in life sciences R&D, has today announced the creation of a new In Vitro Pharmacology Working Group. The group will include liaisons from the US Food and Drug Administration’s Center for Drug Evaluation and Research, as well as representatives […]
Pistoia Alliance Report 2030
This report is intended for all members and friends of the Pistoia Alliance, and any others interested in its work supporting cross-industry collaboration and innovation. It sets out to consider what the life science, biopharma R&D, and healthcare ecosystem might look like in 2030. The objective is to ensure that the Pistoia Alliance, its […]